Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pamela J. Cramer Insider Profile
4 Followers
Pamela J. Cramer, CHRO at Rhythm Pharmaceuticals, holds 13.50K shares in Rhythm Pharmaceuticals (Ticker: RYTM).
Pamela J. Cramer has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Pamela J. Cramer's holdings
Insider Roles
CHRO
Roles that Pamela J. Cramer holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Aug 23, 2022 - Aug 23, 2023
Return:-8.20%
The most profitable trade made by Pamela J. Cramer
Pamela J. Cramer's Trading History
List of latest transactions for each holding click on a transaction to see Pamela J. Cramer's performance on stock
You May Also Like
Pamela J. Cramer insider profile FAQ
What is the percentage of profitable transactions made by Pamela J. Cramer?
The percentage of profitable transactions made by Pamela J. Cramer is ―.
What is the average return per transaction made by Pamela J. Cramer?
The average return per transaction made by Pamela J. Cramer is ―.
What stocks does Pamela J. Cramer hold?
Pamela J. Cramer holds: RYTM stocks.
What was Pamela J. Cramer’s latest transaction?
Pamela J. Cramer latest transaction was an Uninformative Buy of $77.96K.
What was Pamela J. Cramer's most profitable transaction?
Pamela J. Cramer’s most profitable transaction was an Informative Sell of RYTM stock on August 23, 2022. The return on the trade was -8.20%.
What is Pamela J. Cramer's role in Rhythm Pharmaceuticals?
Pamela J. Cramer's role in Rhythm Pharmaceuticals is CHRO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.